4//SEC Filing
Backenroth Samuel 4
Accession 0001493152-23-012789
CIK 0001603207other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 4:36 PM ET
Size
7.1 KB
Accession
0001493152-23-012789
Insider Transaction Report
Form 4
Backenroth Samuel
Chief Financial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-03-31−525,000→ 175,000 total→ Ordinary Shares (525,000 underlying) - Exercise/Conversion
Ordinary Shares
2023-03-31+525,000→ 525,000 total
Footnotes (2)
- [F1]Represents the vesting and settlement of a portion of restricted stock units ("RSUs") previously granted to the Reporting Person. Each RSU represents a contingent right to receive one Ordinary Share, par value NIS 0.01, with an exercise price of NIS 0.01 per Ordinary Share.
- [F2]75% of the RSUs vested on March 31, 2023, with the remaining 25% vesting on August 9, 2024. The RSUs have no expiration date and have an exercise price of NIS 0.01 per Ordinary Share.
Documents
Issuer
Vascular Biogenics Ltd.
CIK 0001603207
Entity typeother
Related Parties
1- filerCIK 0001579887
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 4:36 PM ET
- Size
- 7.1 KB